Molecular Testing
-
June 2, 2022
Harnessing Each Patient’s Data to Help Many More
With: Kaumudi Bhawe, PhDAt Cancer Commons, we don’t just help people navigate cancer treatment; we learn from everyone we help. Here, our Curious Dr. George asks Cancer Commons Clinical Scientist Kaumudi Bhawe, PhD, to share how new knowledge can be captured from every patient to help many more. Curious Dr. George: Cancer Commons has accumulated in-depth data on many hundreds of patients with various cancers. Because of the… Read more »
-
April 13, 2022
Cancer Commons Adapts to Remain True to Our Mission
With:People facing advanced cancer come to Cancer Commons to ensure they have all the information they need to make their best-possible cancer care decisions. Here, Curious Dr. George asks our CFO & COO Shelley Frisbie about recent updates to our organization. Curious Dr. George: You have been the CFO of Cancer Commons for some time and recently added the COO title and duties to… Read more »
-
March 22, 2022
Immunotherapy Approvals Signal a Need for Molecular Testing in Endometrial Cancer Bookmark
George Lundberg, MDMolecular testing often guides choices of immunotherapy, as illustrated in this OncLive story about endometrial cancer.
.
-
March 22, 2022
Biomarker Testing for Cancer Treatment Bookmark
George Lundberg, MDEach person with cancer has unique biomarkers that may determine how well specific treatments might work for them. Learn more from this website all about biomarkers, prepared by the National Cancer Institute.
.
-
March 8, 2022
Using Protein Analysis to Understand Esophageal Cancer Bookmark
George Lundberg, MDIn order to advance knowledge that leads to better treatments for esophageal diseases, biomarkers of genomic, proteomic, and metabolomic types may be required. One company, Stella Diagnostics, received a Biotech Breakthrough Award in 2021 for its proteomics work in this often-neglected cancer.
.
.
-
March 3, 2022
More Information from Less Tissue: Strata Oncology Excels
With: Scott Tomlins, MD, PhDFor a growing number of advanced cancer patients, molecular testing of tumor tissue is an essential step in identifying their best options for treatment. Strata Oncology is one company offering this kind of test. Here, our Curious Dr. George asks two of its leaders what sets Strata apart. Curious Dr. George: No loop is stronger than its weakest link. In the “brain-to-brain” concept of… Read more »
-
June 12, 2021
Improving Access to Genetic Testing and Counseling Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Learn about eReach, a study investigating whether telehealth can provide improved access to genetic testing for people at risk for cancer.
.
-
June 12, 2021
Decoding the Differences between At-Home and Medical Genetic Testing Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Learn about how the cost, access, accuracy, privacy and other aspects of at-home genetic testing compare to medical genetic testing with a specialist.
.
-
June 12, 2021
Tumor Biology Matters Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Results from the Know Your Tumor program shows overall survival benefit for patients with an actionable alteration and who received a matched therapy, compared to those with an actionable alteration and who did not receive a matched therapy.
.
-
June 12, 2021
Multi-Site Precision Promise Study Opens Bookmark
Lola Rahib, PhDArticle from Let’s Win! Pancreatic Cancer: Learn about Precision Promise, an adaptive multi-site clinical trial spearheaded by the Pancreatic Cancer Action Network.
.